True precision medicine in immuno-oncology, challenges, and opportunities
On March 18, Uppsala University Associate Professor Sara Mangsbo will talk about how the future of cancer therapy is becoming personal. Sara co-founded Strike Pharma to further develop the Uppsala University and SciLifeLab Drug Discovery platform co-developed ADAC technology (Adaptable Drug Affinity Conjugates). With current diagnostic tools also, immunotherapy can and should enter the omics-field and the developed […]